FGFR1 and neoplasm: Although sample pairs from only four patients could be obtained, two of these exhibited increased FGFR1 mRNA expression in the post-EGFR-TKI-treatment tumor sample compared to the corresponding pre-treatment tumor sample, suggesting that FGFR1 upregulation occurs in some clinical tumor samples with acquired resistance to EGFR-TKI treatment.